Investigation on heroin and cocaine quality in Luxembourg.

Cocaine Drug consumption facilities Heroin Quality Seizure

Journal

Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624

Informations de publication

Date de publication:
16 09 2021
Historique:
received: 21 05 2021
accepted: 02 09 2021
entrez: 17 9 2021
pubmed: 18 9 2021
medline: 26 11 2021
Statut: epublish

Résumé

Heroin and cocaine are among the most dangerous illicit drugs available and their presence on the market is increasing. These facts have led to the investigation of the quality of heroin and cocaine samples seized in Luxembourg by police and customs but also collected at the national supervised drug consumption facilities. Samples obtained from 2019 to 2020 were analyzed to determine their composition and content using GC-MS, HPLC-UV and LC-Q-ToF. The statistical evaluation of concentration changes depending on the source of collection is based on an ANOVA single factor test and a two-tailed t test. Results showed important differences between seizure and collection sources. For both drugs, customs samples had significantly higher concentrations than police samples and the latter had significantly higher concentrations than samples from drug consumption facilities, whereas for heroin two cutting steps were identified, for cocaine samples only one appears to occur on the local market. Indeed, cocaine samples seized by police consisted of a mixture of low and high concentration samples. The results show that extensive adulteration with pharmacological active and inactive compounds takes place at local levels, which, however, are different for heroin and cocaine. This knowledge on variability of quality of drugs should be considered in the elaboration of drug and harm prevention strategies.

Sections du résumé

BACKGROUND
Heroin and cocaine are among the most dangerous illicit drugs available and their presence on the market is increasing. These facts have led to the investigation of the quality of heroin and cocaine samples seized in Luxembourg by police and customs but also collected at the national supervised drug consumption facilities.
METHODS
Samples obtained from 2019 to 2020 were analyzed to determine their composition and content using GC-MS, HPLC-UV and LC-Q-ToF. The statistical evaluation of concentration changes depending on the source of collection is based on an ANOVA single factor test and a two-tailed t test.
RESULTS
Results showed important differences between seizure and collection sources. For both drugs, customs samples had significantly higher concentrations than police samples and the latter had significantly higher concentrations than samples from drug consumption facilities, whereas for heroin two cutting steps were identified, for cocaine samples only one appears to occur on the local market. Indeed, cocaine samples seized by police consisted of a mixture of low and high concentration samples.
CONCLUSION
The results show that extensive adulteration with pharmacological active and inactive compounds takes place at local levels, which, however, are different for heroin and cocaine. This knowledge on variability of quality of drugs should be considered in the elaboration of drug and harm prevention strategies.

Identifiants

pubmed: 34530816
doi: 10.1186/s12954-021-00544-x
pii: 10.1186/s12954-021-00544-x
pmc: PMC8444575
doi:

Substances chimiques

Illicit Drugs 0
Heroin 70D95007SX
Cocaine I5Y540LHVR

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

97

Informations de copyright

© 2021. The Author(s).

Références

J Psychopharmacol. 2015 Jun;29(6):655-60
pubmed: 25922421
Int J Drug Policy. 2019 Nov;73:7-15
pubmed: 31330276
Harm Reduct J. 2021 Jan 7;18(1):8
pubmed: 33413397

Auteurs

Adèle Bourmaud (A)

Laboratoire national de santé, Service de toxicologie analytique - chimie pharmaceutique, 1, rue Louis Rech, 3555, Dudelange, Luxembourg. adele.bourmaud@lns.etat.lu.

Georges Dahm (G)

Laboratoire national de santé, Service de toxicologie analytique - chimie pharmaceutique, 1, rue Louis Rech, 3555, Dudelange, Luxembourg.

François Meys (F)

Laboratoire national de santé, Service de toxicologie analytique - chimie pharmaceutique, 1, rue Louis Rech, 3555, Dudelange, Luxembourg.

Nicolas Gengler (N)

Laboratoire national de santé, Service de toxicologie analytique - chimie pharmaceutique, 1, rue Louis Rech, 3555, Dudelange, Luxembourg.

Alain Origer (A)

Direction de la Santé, Ministère de la Santé, Allée Marconi - Villa Louvigny, 2120, Luxembourg, Luxembourg.

Serge Schneider (S)

Laboratoire national de santé, Service de toxicologie analytique - chimie pharmaceutique, 1, rue Louis Rech, 3555, Dudelange, Luxembourg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH